US 12,465,645 B2
Anti-viral composition and method for preparing the same
Alexia Reif, Stockton, CA (US)
Filed by Alexia Reif, Stockton, CA (US)
Filed on Apr. 1, 2022, as Appl. No. 17/711,510.
Prior Publication US 2023/0310612 A1, Oct. 5, 2023
Int. Cl. A61K 47/34 (2017.01); A61K 8/9783 (2017.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61P 31/22 (2006.01)
CPC A61K 47/34 (2013.01) [A61K 8/9783 (2017.08); A61K 9/0014 (2013.01); A61K 45/06 (2013.01); A61P 31/22 (2018.01)] 15 Claims
OG exemplary drawing
 
1. A method of treating or preventing herpes simplex virus (HSV), aphthous, and mouth ulcers, comprising contacting a composition with tissue, wherein the composition comprises esculentoside P, arjunglucoside I, and esculentagenic acid.